MedPal AI (LSE:MPAL) NonCurrent Deferred Revenue: £ Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is MedPal AI NonCurrent Deferred Revenue?

MedPal AI LSE:MPAL -4.76% NonCurrent Deferred Revenue is £ Mil as of Feb. 2026. The stock has 1 warning sign investors should review.

Non-Current Deferred Revenue represents the non-current portion of deferred revenue amount as of the balance sheet date. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months.

MedPal AI's non-current deferred revenue for the quarter that ended in Feb. 2026 was £ Mil.

MedPal AI NonCurrent Deferred Revenue Related Terms

MedPal AI NonCurrent Deferred Revenue Historical Data

* Premium members only.

The historical data trend for MedPal AI's NonCurrent Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedPal AI NonCurrent Deferred Revenue Chart

MedPal AI Annual Data
Trend Aug22 Aug23 Aug24 Aug25
NonCurrent Deferred Revenue
- - - -

MedPal AI Semi-Annual Data
Feb24 Aug24 Feb25 Aug25 Feb26
NonCurrent Deferred Revenue - - - - -
What does a NonCurrent Deferred Revenue of £ Mil mean?
MedPal AI (LSE:MPAL) has a NonCurrent Deferred Revenue of £ Mil as of Feb. 2026. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on MedPal AI and its competitors.
Is MedPal AI's NonCurrent Deferred Revenue too high?
MedPal AI's current NonCurrent Deferred Revenue is £ Mil.
How does MedPal AI's NonCurrent Deferred Revenue compare to VEEV and BTSG?
MedPal AI's NonCurrent Deferred Revenue of £ Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Revenue for a Healthcare Providers & Services company?
A good NonCurrent Deferred Revenue depends on the Healthcare Providers & Services industry context. However, NonCurrent Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Revenue mean?
A high NonCurrent Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on MedPal AI and its competitors. MedPal AI's current NonCurrent Deferred Revenue is £ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedPal AI stock overvalued right now?
MedPal AI (LSE:MPAL) has a current NonCurrent Deferred Revenue of £ Mil. The current NonCurrent Deferred Revenue is £ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Revenue calculated?
NonCurrent Deferred Revenue is calculated from a company's financial statements. For MedPal AI (LSE:MPAL), the current NonCurrent Deferred Revenue is £ Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedPal AI Business Description

Other Exchanges Z1N:Germany
Address 71 Queen Victoria Street, Floor 8, London, GBR, EC4V 4AY
MedPal AI PLC is a UK-based digital health and artificial intelligence company focused on the development and commercialisation of AI-enabled healthcare platforms.. Its platform aggregates data across devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights. The Company has two reportable segments, Software and Corporate.